Efficacy and safety of oral low-dose glucocorticoids in patients with estrogen-dependent primary osteoarthritis

Carlos A. Cañas, Carlos J. Osorio, Nicolás Coronel, Magda C. Cepeda, Jorge H. Izquierdo, Fabio Bonilla-Abadía

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Estrogen-dependent osteoarthritis (EDPOA) is a disease of perimenopausal-age women. Their manifestations are polyarticular pain with common co-morbidities (carpal tunnel syndrome, insomnia, fatigue, depression, and fibromyalgia). Based on dual role of glucocorticoids, its trophic action on the chondrocyte and its anti-inflammatory effect, we conducted a prospective interventional cohort study where we evaluate the efficacy and safety of oral low-dose GC in one hundred women with EDPOA. The pain intensity, number of tender joints as well as impact in co-morbidities were analyzed. We conclude that the use of low-dose GC in patients with EDPOA can be an effective and a safe therapeutic option.

Original languageEnglish
Pages (from-to)733-735
Number of pages3
JournalRheumatology International
Volume34
Issue number5
DOIs
StatePublished - May 2014
Externally publishedYes

Keywords

  • Glucocorticoids
  • Menopause
  • Primary osteoarthritis
  • Steroids

Fingerprint

Dive into the research topics of 'Efficacy and safety of oral low-dose glucocorticoids in patients with estrogen-dependent primary osteoarthritis'. Together they form a unique fingerprint.

Cite this